SMS Lifesciences India Ltd.

NSE: SMSLIFE  SECTOR: Pharmaceuticals & Drugs

626.65
+8.05 (1.3%)

Price Summary

Today's High

₹ 638.8

Today's Low

₹ 620

52 Week High

₹ 676.95

52 Week Low

₹ 157

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

189.454279855 Cr.

Enterprise Value

234.080679855 Cr.

No. of Shares

0.3023287 Cr.

P/E

26.34

P/B

1.64

Face Value

₹ 10

Div. Yield

0.24%

Book Value (TTM)

₹  382.9252

CASH

2.4671 Cr.

DEBT

47.0935 Cr.

Promoter Holding

67.99%

EPS (TTM)

₹  23.7887

Sales Growth

61.5827761026688%

ROE

17.2021136924101 %

ROCE

21.8199155967537 %

Profit Growth

4.42745446056727 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year61.58%
3 Year∞%
5 YearNA

Profit Growth (in Cr.)

1 Year155.85%
3 Year1979.54%
5 YearNA

ROE%

1 Year17.2%
3 Year18.82%

ROCE %

1 Year21.82%
3 Year25.67%

Debt/Equity

0.448600952956126

Price to Cash Flow

6.95

Interest Cover Ratio

5.34958441653546

CFO/PAT (5 Yr. Avg.)

NA

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2019 67.99 8.74
Sep 2019 67.99 8.74
Jun 2019 67.99 8.74
Mar 2019 67.99 8.74
Dec 2018 67.99 8.74
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 1979.54231893829% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 25.6740348544846% over the past 3 years.
  • Company’s PEG ratio is 0.169028275368879.
  • The company has an efficient Cash Conversion Cycle of 19.1067006515386 days.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020
Net Sales 92.72 71.56 46.4 46.25 54.78
Total Expenditure 83.06 63.77 43.76 42.55 48.3
Operating Profit 9.65 7.79 2.64 3.71 6.48
Other Income 0.27 0.8 0.3 0.5 0.08
Interest 1.41 1.36 1.17 1.14 1.18
Depreciation 1.76 1.8 1.79 1.89 1.79
Exceptional Items 0 0 0 0 0
Profit Before Tax 6.76 5.43 -0.02 1.17 3.59
Tax 2.29 1.94 0.26 -0.3 1.07
Profit After Tax 4.47 3.49 -0.29 1.47 2.51
Adjusted EPS (Rs) 1.48 1.16 -0.09 0.49 0.83

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019
Net Sales 0 215.89 212.99 344.15
Total Expenditure 0 187.4 199.76 311.69
Operating Profit 0 28.49 13.23 32.46
Other Income 0 1.73 3.08 2.53
Interest 0 6.2 4.21 5.46
Depreciation 0 5.55 5.7 5.77
Exceptional Items 0 0 0 0
Profit Before Tax 0 18.46 6.4 23.76
Tax 0 5.52 -0.1 7.13
Net Profit 0 12.94 6.5 16.63
Adjusted EPS (Rs.) -1.85 12943.2 21.5 55.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity and Liabilities
Share Capital 0.01 0.01 3.02 3.02
Total Reserves -0.01 81.83 85.38 101.96
Borrowings 0 15.96 15.19 27.2
Other N/C liabilities 0 9.44 9.16 10.21
Current liabilities 0.01 74 65.25 114.6
Total Liabilities 0.01 181.24 178.01 257
Assets
Net Block 0 72.68 68.38 87.13
Capital WIP 0 0.17 7.09 1.31
Investments 0 0.85 5.81 26.89
Loans & Advances 0 4.72 5.58 4.78
Other N/C Assets 0.01 2.92 1.08 1.05
Current Assets 0 99.9 90.07 135.84
Total Assets 0.01 181.24 178.01 257
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019
Profit Before Tax 0 18.46 6.4 23.76
Adjustment 0 8.68 7.98 8.65
Working Capital Changes 0 -2.45 -5.62 1.2
Tax Paid 0 -5.03 -0.75 -6.35
Operating Cash Flow 0 19.66 8 27.26
Investing Cash Flow 0 -7.53 -6.84 -43.27
Financing Cash Flow 0 -12.34 -0.81 17.6
Net Cash Flow 0 -0.21 0.36 1.59

Corporate Actions

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Company News

SMS Lifesciences Stock Price Analysis and Quick Research Report. Is SMS Lifesciences an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into SMS Lifesciences and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 27.2607 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. SMS Lifesciences has a Debt to Equity ratio of 0.448600952956126 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In SMS Lifesciences , the EPS growth was 155.845753926138 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, SMS Lifesciences has OPM of 8.64063389208099 % which is a bad sign for profitability.
     
  • ROE: SMS Lifesciences have a average ROE of 17.2021136924101 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about SMS Lifesciences

X